Worldquant Millennium Advisors LLC reduced its stake in Globe Life Inc. (NYSE:GL - Free Report) by 36.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 48,392 shares of the company's stock after selling 27,197 shares during the quarter. Worldquant Millennium Advisors LLC owned about 0.06% of Globe Life worth $5,397,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Albion Financial Group UT purchased a new position in shares of Globe Life in the 4th quarter valued at approximately $28,000. Rakuten Securities Inc. purchased a new position in Globe Life during the 4th quarter worth approximately $28,000. Avalon Trust Co purchased a new position in Globe Life during the 4th quarter worth approximately $41,000. EverSource Wealth Advisors LLC raised its position in Globe Life by 32.7% during the 4th quarter. EverSource Wealth Advisors LLC now owns 365 shares of the company's stock worth $41,000 after buying an additional 90 shares during the last quarter. Finally, Platinum Investment Management Ltd. purchased a new position in Globe Life during the 4th quarter worth approximately $45,000. 81.61% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on GL shares. Keefe, Bruyette & Woods raised their price target on shares of Globe Life from $137.00 to $145.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 12th. Wall Street Zen raised shares of Globe Life from a "hold" rating to a "buy" rating in a research report on Friday, May 16th. Piper Sandler reduced their price target on shares of Globe Life from $152.00 to $147.00 and set an "overweight" rating for the company in a research report on Friday, May 2nd. Morgan Stanley raised their price target on shares of Globe Life from $117.00 to $125.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Finally, Wells Fargo & Company reduced their price target on shares of Globe Life from $140.00 to $139.00 and set an "overweight" rating for the company in a research report on Tuesday, May 6th. Four analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Globe Life currently has an average rating of "Moderate Buy" and an average price target of $137.73.
View Our Latest Stock Report on Globe Life
Insider Transactions at Globe Life
In other news, CEO Frank M. Svoboda sold 6,019 shares of Globe Life stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $122.51, for a total transaction of $737,387.69. Following the transaction, the chief executive officer now owns 31,298 shares in the company, valued at $3,834,317.98. The trade was a 16.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.51% of the company's stock.
Globe Life Price Performance
Globe Life stock traded down $0.05 during trading on Friday, reaching $119.51. The company had a trading volume of 385,967 shares, compared to its average volume of 827,437. Globe Life Inc. has a 1-year low of $76.55 and a 1-year high of $133.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The firm's 50-day simple moving average is $122.78 and its 200 day simple moving average is $118.17. The firm has a market capitalization of $9.86 billion, a PE ratio of 10.00 and a beta of 0.56.
Globe Life (NYSE:GL - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $3.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.24 by ($0.17). Globe Life had a return on equity of 22.32% and a net margin of 18.53%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.49 billion. During the same period last year, the firm earned $2.78 EPS. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. As a group, equities research analysts anticipate that Globe Life Inc. will post 13.87 earnings per share for the current fiscal year.
Globe Life Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Thursday, July 3rd will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Thursday, July 3rd. This represents a $1.08 annualized dividend and a dividend yield of 0.90%. Globe Life's dividend payout ratio is presently 8.79%.
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Recommended Stories

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.